Keykuda from Merck abandons liver cancer study – Seeking Alpha February 20, 2019 11:33 AM by admin [ad_1] Merck's Keykuda ignores liver cancer in search of alpha FDA Approves Adjuvant Pembrolizumab In OncLive Stage III Melanoma Treatment View full coverage on Google News [ad_2] Source link